- Series E round led by existing top-tier life science investors Wellington Partners and HBM Healthcare Investments
- Data from AdrenOSS-2 on early treatment start with Adrecizumab in septic shock to be presented at DIVI, December 2-4, 2020
- Virologists and epidemiologists call for continuous testing to contain the pandemic
- The DiagnostikNet-BB works on many levels of the test chain
- IMDB develops new project family for comprehensive COVID-19 diagnostics
ProBioGen AG announced the closing of a master service agreement with Asahi Kasei Pharma. As an expert CDMO in high-titer cell line development till large scale GMP manufacturing, ProBioGen will use its proprietary technologies, like the…
Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”) announces 2015229103 entitled “Antibody molecules to LAG- 3 and uses thereof” by the Australian Patent Office.
The European Research Council (ERC) is providing 10 million euros in funding for an interdisciplinary, collaborative project to structurally and biophysically analyze selected photo-receptors and develop them into “OptoGPCRs”, light-controlled…
Eternygen announces today the first closing of its Series A2 funding round led by new anchor investor Evotec SE and additional funding from venture capital firms Epidarex Capital, IBB Ventures and a number of family offices. The new investment…
The “Mobile Autonomy for Children in End-stage Heart Failure” (MACH) project wins the 2020 Horizon Impact Award. This project was an international collaboration between RWTH Aachen University, Uniklinik RWTH Aachen, Newcastle upon Tyne Hospitals NHS…
Double interview with Prof. Dr. Christian Drosten, Director of the Institute of Virology at Charité Berlin and speaker at the World Health Summit, and Prof. Dr. Detlev Ganten, President and Founder of the World Health Summit.
Current findings on COVID-19, new global strategies for pandemic control and prevention, the role of Europe and the WHO in global health will be the core topics of this year's World Health Summit from October 25-27 in Berlin.
The past five years have contributed to intensive networking within the Healthcare Industry Cluster Berlin-Brandenburg. This has created the prerequisites for interdisciplinary, cross-sectoral and agile work on future topics and solutions for complex…
